| Original language | Korean |
|---|---|
| Journal | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
| State | Published - 2019.10.1 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
The comparison of Carfilzomib, and dexamethasone versus pomalidomide-based combination chemotherapy after a 2nd-line therapy in relapsed and refractory multiple myeloma patients
Research output: Contribution to journal › Journal article › peer-review